To include your compound in the COVID-19 Resource Center, submit it here.

Dynavax gains on Heplisav update

Dynavax Technologies Corp. (NASDAQ:DVAX) gained $0.41 (17%) to $2.84

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE